Non-responders to bevacizumab (Avastin) therapy of choroidal neovascular lesions.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  British Journal of Ophthalmology

• Publication date

  2008-06-01

• Fields of study

  Medicine

• Identifiers
  PMID 18523095PMCID PMC2666011
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• STANDARDIZED VISUAL ACUITY RESULTS ASSOCIATED WITH PRIMARY VERSUS SECONDARY BEVACIZUMAB (AVASTIN) TREATMENT FOR CHOROIDAL NEOVASCULARIZATION IN AGE-RELATED MACULAR DEGENERATION

  2007cited by this paper
• Non-responders to bevacizumab (Avastin) therapy of choroidal neovascular lesions

  2007cited by this paper
• Ranibizumab in neovascular age-related macular degeneration

  2006cited by this paper
• Ranibizumab for neovascular age-related macular degeneration.

  2006cited by this paper
• Avastin and new treatments for AMD: where are we?

  2006cited by this paper

• The Therapeutic Effect of a Biodegradable Long-Acting Intravitreal Implant Containing CGK012 on Neovascular Age-Related Macular Degeneration by Promoting β-Catenin Degradation

  2025cites this paper
• In vivo efficacy of NRL knockdown with cell-penetrating siRNA in retinal degeneration

  2025cites this paper
• Potential Impact of N6-Methyladenosine RNA Methylation on Vision Function and the Pathological Processes of Ocular Diseases: New Discoveries and Future Perspectives.

  2022cites this paper
• Офтальмология/Ophthalmology in Russia

  2021cites this paper
• Protection against light‐induced retinal degeneration via dual anti‐inflammatory and anti‐angiogenic functions of thrombospondin‐1

  2020influential citation
• Subgroups and Features of Poor Responders to Anti-Vascular Endothelial Growth Factor Treatment in Eyes with Neovascular Age-Related Macular Degeneration

  2020cites this paper
• Targeting Neurovascular Interaction in Retinal Disorders

  2020cites this paper
• Cyclic stretch-induced VEGF expression is mediated by TGF-β in retinal pigment epithelial cells

  2020influential citation
• Adding a Corticosteroid or Switching to Another Anti-VEGF in Insufficiently Responsive Wet Age-Related Macular Degeneration

  2019cites this paper
• OPTH_A_224456 2403..2409

  2019cites this paper
• Dyslipidemia in retinal metabolic disorders

  2019cites this paper
• Photodynamic therapy combined with intravitreal bevacizumab for the management of choroidal neovascularization resistant to bevacizumab monotherapy. A case series

  2019cites this paper
• Cyclic stretch-induced VEGF expression is mediated by TGF-β in retinal pigment epithelial cells

  2019influential citation
• Volume-Rendered Projection-Resolved OCT Angiography: 3D Lesion Complexity Is Associated With Therapy Response in Wet Age-Related Macular Degeneration

  2018cites this paper
• The role of posterior vitreous detachment on the efficacy of anti-vascular endothelial growth factor intravitreal injection for treatment of neovascular age-related macular degeneration

  2018cites this paper
• Galectin-3 Inhibition by a Small-Molecule Inhibitor Reduces Both Pathological Corneal Neovascularization and Fibrosis

  2017cites this paper
• Influence of Vitreomacular Adhesion on Anti-Vascular Endothelial Growth Factor Treatment for Neovascular Age-Related Macular Degeneration

  2017cites this paper
• Therapeutic targeting of the angiopoietin–TIE pathway

  2017cites this paper
• Chemical Proteomics Reveals Soluble Epoxide Hydrolase as a Therapeutic Target for Ocular Neovascularization.

  2017cites this paper
• The Effect of CM082, an Oral Tyrosine Kinase Inhibitor, on Experimental Choroidal Neovascularization in Rats

  2017cites this paper
• Influence of vitreomacular interface on anti-vascular endothelial growth factor treatment outcomes in neovascular age-related macular degeneration

  2017cites this paper
• Neovascular Age-Related Macular Degeneration Disease Quiescence with Visual Acuity Stability in a Subgroup of Patients Following PRN Treatment

  2017cites this paper
• The non-Responsiveness to Anti-Vascular Endothelial Growth Factor Agents in the Treatment of Neovascularage-Related Macular Degeneration

  2017cites this paper
• UNTREATED OBSTRUCTIVE SLEEP APNEA HINDERS RESPONSE TO BEVACIZUMAB IN AGE-RELATED MACULAR DEGENERATION

  2016cites this paper
• Detection of aqueous VEGF concentrations before and after intravitreal injection of anti-VEGF antibody using low-volume sampling paper-based ELISA

  2016cites this paper
• SHORT-TERM SAFETY PROFILE OF INTRAVITREAL ZIV-AFLIBERCEPT

  2016cites this paper
• CFH Y402H and VEGF Polymorphisms and Anti-VEGF Treatment Response in Exudative Age-Related Macular Degeneration

  2016cites this paper
• Das klinische Ergebnis eines Therapiewechsels von Ranibizumab und/oder Bevacizumab zu Aflibercept bei neovaskulärer altersabhängiger Makuladegeneration (AMD)

  2016cites this paper
• Mechanistic and therapeutic evaluation of a novel antiantiogenic small molecule

  2016influential citation
• A novel small molecule ameliorates ocular neovascularisation and synergises with anti-VEGF therapy

  2016cites this paper
• Artemisinin protects human retinal pigment epithelial cells from hydrogen peroxide-induced oxidative damage through activation of ERK/CREB signaling

  2016cites this paper
• Deletion of miR-150 Exacerbates Retinal Vascular Overgrowth in High-Fat-Diet Induced Diabetic Mice

  2016cites this paper
• A Revised Hemodynamic Theory of Age-Related Macular Degeneration.

  2016cites this paper
• Effects of Vitreomacular Adhesion on Age-Related Macular Degeneration

  2015cites this paper
• Cyclic AMP Response Element Binding Protein Mediates Pathological Retinal Neovascularization via Modulating DLL4-NOTCH1 Signaling

  2015cites this paper
• Antiangiogenic Effects of Topically Administered Multiple Kinase Inhibitor, Motesanib (AMG 706), on Experimental Choroidal Neovascularization in Mice

  2015cites this paper
• PHARMACOGENOMICS OF RESPONSE TO ANTI-VEGF THERAPY IN EXUDATIVE AGE-RELATED MACULAR DEGENERATION

  2015cites this paper
• Diosmetin protects against retinal injury via reduction of DNA damage and oxidative stress

  2015cites this paper
• Effects of Vitreomacular Traction on Ranibizumab Treatment Response in Eyes with Neovascular Age-related Macular Degeneration

  2015cites this paper
• Resveratrol Inhibits Hypoxia-Induced Vascular Endothelial Growth Factor Expression and Pathological Neovascularization

  2015cites this paper
• Aflibercept: a review of its use in the treatment of choroidal neovascularization due to age-related macular degeneration

  2015cites this paper
• Choose the right treatment for the right patients

  2015cites this paper
• Wnting out ocular neovascularization: using nanoparticle delivery of very-low density lipoprotein receptor extracellular domain as Wnt pathway inhibitor in the retina.

  2015cites this paper
• Current choice of treatments for neovascular AMD

  2015cites this paper
• VITREOMACULAR TRACTION AFFECTS ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT OUTCOMES FOR EXUDATIVE AGE-RELATED MACULAR DEGENERATION

  2015cites this paper
• Prospective, Randomized Intervention Study Comparing Retinal Pigment Epithelium-Choroid Graft Surgery and Anti-VEGF Therapy in Patients with Exudative Age-Related Macular Degeneration

  2015cites this paper
• Aflibercept Traps Galectin-1, an Angiogenic Factor Associated with Diabetic Retinopathy

  2015cites this paper
• Synthesis and Biological Evaluation of Novel Homoisoflavonoids for Retinal Neovascularization.

  2015cites this paper
• Aflibercept: a review of its use in the treatment of choroidal neovascularization due to age-related macular degeneration

  2015cites this paper
• MACULAR EPIRETINAL BRACHYTHERAPY IN TREATED AGE-RELATED MACULAR DEGENERATION (MERITAGE): Month 24 Safety and Efficacy Results

  2014cites this paper
• Synthesis and Mechanistic Studies of a Novel Homoisoflavanone Inhibitor of Endothelial Cell Growth

  2014cites this paper
• Ocular delivery of macromolecules.

  2014cites this paper
• POOR RESPONDERS TO BEVACIZUMAB PHARMACOTHERAPY IN AGE-RELATED MACULAR DEGENERATION AND IN DIABETIC MACULAR EDEMA DEMONSTRATE INCREASED RISK FOR OBSTRUCTIVE SLEEP APNEA

  2014cites this paper
• Angiopoietin-1 suppresses choroidal neovascularization and vascular leakage.

  2014cites this paper
• ROLE OF POSTERIOR VITREOUS DETACHMENT ON OUTCOME OF ANTI–VASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT IN AGE-RELATED MACULAR DEGENERATION

  2014cites this paper
• POLYMORPHISMS IN THE APOE GENE AND THE LOCATION OF RETINAL FLUID IN EYES WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION

  2014cites this paper
• Predictive factors for non-response to intravitreal ranibizumab treatment in age-related macular degeneration

  2014cites this paper
• Risk factors of a reduced response to ranibizumab treatment for neovascular age-related macular degeneration – evaluation in a clinical setting

  2013cites this paper
• Antiangiogenic effects of tivozanib, an oral VEGF receptor tyrosine kinase inhibitor, on experimental choroidal neovascularization in mice.

  2013cites this paper
• Antiangiogenic Effects of Axitinib, an Inhibitor of Vascular Endothelial Growth Factor Receptor Tyrosine Kinase, on Laser-Induced Choroidal Neovascularization in Mice

  2013cites this paper
• Anti-VEGF-refractory Exudative Age-related Macular Degeneration: Differential Response According to Features on Optical Coherence Tomography

  2013cites this paper
• The Frequency of the Nonresponsiveness to Intravitreal Injection of the Anti-Vascular Endothelial Growth Factor Agent in Neovascular Age Related Macular Degeneration

  2013influential citation
• Retinal angiogenesis suppression through small molecule activation of p53.

  2013cites this paper
• POLYPOIDAL CHOROIDAL VASCULOPATHY: Evidence-Based Guidelines for Clinical Diagnosis and Treatment

  2013cites this paper
• Vascular endothelial growth factor-C secretion is increased by advanced glycation end-products: possible implication in ocular neovascularization

  2012cites this paper
• Safety of Submacular Suprachoroidal Drug Administration via a Microcatheter: Retrospective Analysis of European Treatment Results

  2012cites this paper
• Literature Review of Recombinant Tissue Plasminogen Activator Used for Recent-Onset Submacular Hemorrhage Displacement in Age-Related Macular Degeneration

  2012cites this paper
• REDUCTION OF LASER-INDUCED CHOROIDAL NEOVASCULARIZATION BY INTRAVITREAL VASOHIBIN-1 IN MONKEY EYES

  2012cites this paper
• Notch-dependent VEGFR3 upregulation allows angiogenesis without VEGF–VEGFR2 signalling

  2012cites this paper
• A SYSTEMATIC REVIEW OF THE ADVERSE EVENTS OF INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR INJECTIONS

  2011cites this paper
• Suppression of choroidal neovascularization by vasohibin-1, a vascular endothelium-derived angiogenic inhibitor.

  2011cites this paper
• The neonatal Fc receptor is expressed by human retinal pigment epithelial cells and is downregulated by tumour necrosis factor-alpha

  2011cites this paper
• Surgical Treatment of Age-Related Macular Degeneration

  2011cites this paper
• Hypoxia-induced angiogenesis: good and evil.

  2011cites this paper
• Pilot Study of Safety and Effect of Combined Intravitreal Bevacizumab and Methotrexate for Neovascular Age-Related Macular Degeneration

  2011cites this paper
• INTRAVITREAL INFLIXIMAB IN PATIENTS WITH MACULAR DEGENERATION WHO ARE NONRESPONDERS TO ANTIVASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY

  2010cites this paper
• Full Macular Translocation for Choroidal Neovascularization in the Era of Intravitreal Pharmacological Therapy

  2010cites this paper
• Neovascular age-related macular degeneration and anti-VEGF nonresponders

  2010cites this paper
• ACUTE STEVENS-JOHNSON SYNDROME: OPHTHALMOLOGIC EVALUATION AND MANAGEMENT

  2010cites this paper
• Kombinirano liječenje senilne neovaskularne makularne degeneracije primjenom bevacizumaba i fotodinamske terapije : doktorski rad

  2010cites this paper
• Therapeutic monoclonal antibodies in ophthalmology.

  2009cites this paper
• Surgical choroidal neovascular membrane removal in the era of anti-vascular endothelial growth factor agents

  2009cites this paper
• Systemic bevacizumab (Avastin) therapy for exudative neovascular age-related macular degeneration. The BEAT-AMD-Study

  2009cites this paper
• Makulatranslokation – eine Therapie der neovaskuläre Makuladegeneration im Zeitalter der Anti-VEGF-Therapie?

  2009cites this paper
• Ageing and visual field data

  2007cites this paper
• Retinal Angiogenesis Suppression through Small Molecule Retinal Angiogenesis Suppression through Small Molecule Activation of p53 Activation of p53

  year unknowncites this paper
• Usage and Distribution for Commercial Purposes Requires Written Permission. Is Spectral-domain Optical Coherence Tomography Always Able to Detect the Anti-vascular Endothelial Growth Factor Action on Neovascular Membrane? Borgia Et Al.: Is Spectral-domain Optical Coherence Tomography Always Able to

  year unknowncites this paper